Table 4.
Effect of factors at ART initiation on mortality of patients
| Factor | Unadjusted analysis | Adjusted analysis | ||||
|---|---|---|---|---|---|---|
| Hazard ratio | 95 % CI | p-value | Hazard ratio | 95 % CI | p-value | |
| Sex | 0.016 | 0.040 | ||||
| Male | 1 (ref) | 1 (ref) | ||||
| Female | 0.57 | 0.36–0.90 | 0.61 | 0.38–0.98 | ||
| Age | 0.051 | 0.039 | ||||
| 15–34 | 1 (ref) | 1 (ref) | ||||
| ≥35 | 1.64 | 0.98–2.74 | 1.72 | 1.01–2.92 | ||
| BMI | 0.019 | 0.023 | ||||
| ≥18.5 | 1 (ref) | 1 (ref) | ||||
| <18.5 | 1.82 | 1.12–2.95 | 1.65 | 1.00–2.72 | ||
| Missing | 3.02 | 1.08–8.41 | 3.97 | 1.33–11.91 | ||
| CD4 count (cells/μL) | 0.021 | 0.010 | ||||
| ≤250 | 1 (ref) | 1 (ref) | ||||
| >250 | 0.66 | 0.28–1.54 | 0.60 | 0.25–1.47 | ||
| Missing | 1.87 | 1.13–3.10 | 2.09 | 1.19–3.69 | ||
| WHO stage | <0.001 | |||||
| I & II | 1 (ref) | |||||
| III & IV | 3.68 | 2.02–6.71 | ||||
| Year of ART initiation | 0.535 | 0.859 | ||||
| 2008 | 1 (ref) | 1 (ref) | ||||
| 2009 | 1.07 | 0.57–2.01 | 0.95 | 0.49–1.84 | ||
| 2010 | 1.48 | 0.81–2.68 | 1.25 | 0.67–2.31 | ||
| 2011 | 1.46 | 0.68–3.12 | 1.07 | 0.47–2.45 | ||
| Route of HIV testing | 0.010 | 0.004 | ||||
| CRH | 1 (ref) | 1 (ref) | ||||
| HIV serosurvey | 0.47 | 0.28–0.81 | 0.43 | 0.25–0.74 | ||
| Missing | 1.07 | 0.55–2.07 | 1.07 | 0.54–2.10 | ||